129 related articles for article (PubMed ID: 29572120)
1. VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis
.
Li T; Yu J; Luo X; Ren W; Zhang Y; Cao B
Pathol Res Pract; 2018 Apr; 214(4):560-564. PubMed ID: 29572120
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
Kim JY; Jeon TJ; Bae BN; Kwon JE; Kim HJ; Park K; Shin E
APMIS; 2013 Feb; 121(2):95-104. PubMed ID: 23030255
[TBL] [Abstract][Full Text] [Related]
4. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract][Full Text] [Related]
5. [The expression of VEGF-C, VEGFR-3 and its predictive value on lymph node metastasis and prognosis of gastric cancer].
Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1058-61. PubMed ID: 17074247
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
9. The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.
Zhu X; Wang Y; Xue W; Wang R; Wang L; Zhu ML; Zheng L
Cancer Biol Ther; 2019; 20(4):497-504. PubMed ID: 30380970
[TBL] [Abstract][Full Text] [Related]
10. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
12. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients.
Klasa-Mazurkiewicz D; Jarząb M; Milczek T; Lipińska B; Emerich J
Pol J Pathol; 2011; 62(1):31-40. PubMed ID: 21574104
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
[TBL] [Abstract][Full Text] [Related]
15. Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer.
Doi Y; Yashiro M; Yamada N; Amano R; Ohira G; Komoto M; Noda S; Kashiwagi S; Kato Y; Fuyuhiro Y; Hirakawa K
Cancer Sci; 2010 Jun; 101(6):1529-35. PubMed ID: 20367641
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
Cheng H; Wang X; Li T; Chen L
Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis.
Huang JY; Xu YY; Li M; Sun Z; Zhu Z; Song YX; Miao ZF; Wu JH; Xu HM
Ann Surg Oncol; 2013 Nov; 20(12):3927-34. PubMed ID: 23892524
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis.
Hong L; Han Y; Yang J; Zhang H; Jin Y; Brain L; Li M; Zhao Q
Gene; 2013 Oct; 529(1):69-72. PubMed ID: 23954221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
